Brief: Travere Therapeutics - Receives USPTO Notice Of Allowance For Filspari Patent In FSGS
23/09/2026 12:05
BRIEF-Travere Therapeutics - Receives USPTO Notice Of Allowance For Filspari Patent In FSGS Sept 23 (Reuters) - Travere Therapeutics, Inc. TVTX.O:
TRAVERE THERAPEUTICS, - RECEIVES USPTO NOTICE OF ALLOWANCE FOR FILSPARI PATENT IN FSGS
TRAVERE THERAPEUTICS, - TO SUBMIT ISSUED PATENT FOR FDA ORANGE BOOK LISTING
Source text: ID:nBw47PYt0a
Further company coverage: TVTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Travere Therapeutics
See all newsBrief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Travere Therapeutics - Receives USPTO Notice Of Allowance For Filspari Patent In FSGS
Brief: Travere Therapeutics Announces Planned Chief Executive Officer Transition
Brief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule